Methylphenidate warnings updated

Prescribing information for methylphenidate is being updated following a review of the drug's safety conducted by the EMEA earlier this year.

The agency concluded that the benefits of medicines containing methylphenidate outweigh their risks when used to treat ADHD in children aged six years and above.

However, prescribing advice for these products has been updated to emphasise the need to screen and monitor for cardiovascular and psychiatric problems before and during treatment.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Free online vestibular rehabilitation tool 'highly effective' for vertigo symptoms

Free online vestibular rehabilitation tool 'highly effective' for vertigo symptoms

GPs should consider online vestibular rehabilitation...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Evorel and galantamine.
Use our constantly...

Thiazides better than ACE inhibitors as first-line antihypertensives, large-scale analysis suggests
Blood Glucose Testing Strips and Meters

Blood Glucose Testing Strips and Meters

Compatible test strips for blood glucose meters.